Pharmicell Co., Ltd. (KRX:005690)
South Korea flag South Korea · Delayed Price · Currency is KRW
19,770
-30 (-0.15%)
At close: Apr 29, 2026

Pharmicell Revenue

Pharmicell had revenue of 3.65B KRW in the quarter ending June 30, 2014, a decrease of -58.16%. This brings the company's revenue in the last twelve months to 23.94B, down -3.60% year-over-year. In the year 2013, Pharmicell had annual revenue of 33.41B with 200.63% growth.

Revenue (ttm)
23.94B
Revenue Growth
-3.60%
P/S Ratio
49.54
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.19T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 201333.41B22.29B200.63%
Dec 31, 201211.11B829.38M8.07%
Dec 31, 201110.28B3.07B42.47%
Dec 31, 20107.22B28.94M0.40%
Dec 31, 20097.19B-1.14B-13.68%
Dec 31, 2008 Pro Pro Pro
Dec 31, 2007 Pro Pro Pro
Dec 31, 2006 Pro Pro Pro
Dec 31, 2005 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
GC Corp.2.45T
Chabiotech1.27T
Hugel425.11B
Medy-Tox247.29B
MEDIPOST73.66B
Onconic Therapeutics53.39B
SillaJen9.23B
GI Innovation5.84B
Revenue Rankings